Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006
Open accessAbstract
Following an application from CreaNutrition AG submitted pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of the United Kingdom, the Panel on Dietetic Products, Nutrition and Allergies was asked to deliver an opinion on the scientific substantiation of a health claim related to oat beta glucan and lowering of blood LDL and total cholesterol. Oat beta-glucan is sufficiently characterised. Lowering blood LDL-cholesterol concentrations is a beneficial physiological effect by decreasing the risk of coronary heart disease. The applicant identified a total of 22 references, which included three meta-analyses and 19 randomised controlled trials, as being pertinent to the health claim. In weighing the evidence, the Panel took into account that most of the trials investigating the effects of oat beta-glucan at doses of at least 3 g/d have shown a statistically significant decrease in LDL-cholesterol concentrations, and that there was strong evidence supporting the biological plausibility of the effect. The Panel concludes that a cause and effect relationship has been established between the consumption of oat beta-glucan and lowering of blood LDL-cholesterol concentrations. The following wording reflects the scientific evidence: "Oat beta-glucan has been shown to lower/reduce blood cholesterol. Blood cholesterol lowering may reduce the risk of (coronary) heart disease". The Panel considers that, in order to bear the claim, foods should provide at leas…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The evidence for their LDL-C lowering efficacy is considered sufficiently strong that all have related FDA, Health Canada, and/or EFSA approved health claims.
“The evidence for their LDL-C lowering efficacy is considered sufficiently strong that all have related FDA, Health Canada, and/or EFSA approved health claims.[1][2][3][4][5][6][7]”
From Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials (2018) · cites this paper as [7]
The citation lists haven’t been fetched yet
References 56 · Cited by 235
- Authors
- EFSA Panel on Dietetic Products, N. A. A. (.
- Corresponding author
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
- Venue
- EFSA Journal
- Publisher
- Wiley
- Published
- 2010-12
- Volume
- 8
- Issue
- 12
- Pages
- 1885-1885
- ISSN
- 1831-4732 (ISSN-L)
- PMC
- PMC13085209
- OpenAlex
- W2553141740
- Cited by
- 235
- References
- 56
- Citations by year
- 2026: 15 · 2025: 4 · 2024: 15 · 2023: 11 · 2022: 21 · 2021: 14 · 2020: 21 · 2019: 17 · 2018: 10 · 2017: 18 · 2016: 17 · 2015: 16 · 2014: 24 · 2013: 12 · 2012: 11
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- EFSA Journal (publishedVersion, cc-by-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Consumer Attitudes and Food Labeling
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- oat β-glucan, LDL cholesterol lowering, serum cholesterol, coronary heart disease risk, health claim substantiation, dietary fiber, Regulation (EC) No 1924/2006, functional foods
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
